Of course, if this testing infrastructure doesn't already exist, I imagine creating it would be too slow to help with this particular plague.
Of course, if this testing infrastructure doesn't already exist, I imagine creating it would be too slow to help with this particular plague.
there's other approaches to make "organs on a chip" for drug trial screening, since lab models with only one type of cells don't capture the effects of other types, but it's really not fully baked yet.
Your “first level” is something we already do with primary and immortalized cells and it can be a useful model. Your next level would be called co-culture and it also is something we already do. These can be static cultures or connected to flow systems or bioreactors or whatever. These are imperfect models, but they can help to yield useful answers for questions in the model’s scope. The closest fidelity to human immune systems would be animal models, and the closest of these would be Rhesus macaques, and indeed these are used for vaccine development.
No, you can't approximate a human immune system with red and white blood cells in a container of liquid. No, adding some other cells in there won't help. If that were effective, we'd be doing it already. You are either overestimating your own ingenuity or underestimating the ingenuity of tens of thousands of scientists, doctors, and engineers.
The answer is no, for somewhat obvious reasons. The human immune system involves many organs and tissues and cells working together in very complex ways.
And I think your charitable interpretation is quite a bit too charitable. OP did not say anything like "why doesn't it work like I think it would".
For the record, my main intention was to get an expert to say something that would gratify my curiosity and that of other readers. I hadn't heard of it before, so I assumed it was likely impractical at the moment, but guessed that technology would eventually get there.
Also, are you an expert in this field? Your sibling comment seems to be saying "yes they are working on it, no it's not practical yet except for HIV" (I presume because HIV infects white blood cells), which is at odds with your second paragraph. (Edit: Though, to be very precise, the examples from the sibling comment are about measuring infectivity and—I guess—the impact of drugs, not immune response.) It would be ironic if a non-expert gave an ignorant dismissal of a question for being ignorant.